Revised SPCs: Mayzent (siponimod) film-coated tablets
Basal cell carcinoma is now listed as a potential adverse effect of treatment, with common frequency, and the warnings/precautions section on cutaneous neoplasms has been updated.
Source:
electronic Medicines compendium